| 2026 |
Khetan, R., Rajapaksha, W., Nturubika, B. D., Gillam, T. A., Brooks, D. A., Garg, S., . . . Eldi, P. (2026). Targeting F2R/PAR1 with ligand decorated lipid nanocarriers for enhanced drug delivery into ovarian cancer cells. Frontiers in Drug Delivery, 5, 1727958-01-1727958-15. DOI Scopus2 WoS2 |
| 2025 |
Hindes, M. T., McElligott, A. M., Best, O. G., Ward, M. P., Selemidis, S., Miles, M. A., . . . Brooks, D. A. (2025). Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer. Cancer Letters, 611(217441), 217441-1-217441-18. DOI Scopus24 WoS25 Europe PMC17 |
| 2025 |
Heatlie, J. K., Lazniewska, J., Moore, C. R., Johnson, I. R. D., Nturubika, B. D., Williams, R., . . . Brooks, D. A. (2025). Extracellular Vesicles and Tunnelling Nanotubes as Mediators of Prostate Cancer Intercellular Communication. Biomolecules, 15(1), 23. DOI Scopus12 WoS11 Europe PMC7 |
| 2024 |
Nturubika, B. D., Guardia, C. M., Gershlick, D. C., Logan, J. M., Martini, C., Heatlie, J. K., . . . Johnson, I. R. D. (2024). Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression. British Journal of Cancer, 131(8), 1263-1278. DOI Scopus6 WoS7 Europe PMC5 |
| 2024 |
Nturubika, B. D. -D., Logan, J., Johnson, I. R. D., Moore, C., Li, K. L., Tang, J., . . . Brooks, D. A. (2024). Components of the Endosome-Lysosome Vesicular Machinery as Drivers of the Metastatic Cascade in Prostate Cancer.. Cancers, 17(1), 43. DOI Scopus4 WoS4 Europe PMC4 |